Cognitive impairment in late life depression is prevalent, disabling, and heterogeneous. Although mild cognitive impairment in depression does not usually progress to dementia, accurate assessment of cognition is vital to prognosis and treatment planning. For example, executive dysfunction often accompanies late-life depression, influences performance across cognitive domains, and is associated with poor antidepressant treatment outcomes. Here, we review how assessment can capture dysfunction across cognitive domains, and discuss cognitive trajectories frequently observed in late-life depression in the context of the neurobiology of this disorder. Furthermore we review the efficacy of a sample of interventions tailored to specific cognitive profiles.
Introduction
Major depression in the elderly often presents with cognitive impairment. Mild cognitive deficits in memory, processing speed and executive functioning are particularly common in late-life depression 1, 2 . Executive functions are control mechanisms that modulate aspects of emotion and cognition, and disruption to these processes is associated with poor course of illness and worse clinical outcomes of late-life depression [3] [4] [5] [6] [7] . In some cases, depression may present concomitantly with 8 , or even precede 9 , dementing disorders characterized by diffuse cognitive deficits. The variability in the cognitive profile of geriatric depression suggests this syndrome represents a heterogeneous group of disorders requiring careful treatment planning and close neuropsychiatric follow-up. In this review, we discuss the relevance of cognitive impairment to the care of geriatric depression. We do so by first describing the various cognitive trajectories and associated clinical manifestations of cognitive impairment independent of processing speed. We followed up these findings with a second study that demonstrated deficits in that semantic organizational strategy use (clustering "like" words together during recall) on a verbal memory task accounted for both verbal memory performance and treatment response 26 . These studies showed that semantic organization predicts poor response to antidepressant drug treatment regardless of the task by which it is elicited 26 .
Failure to achieve remission following treatment with escitalopram in late-life depression is associated with decreased grey matter volume in the dorsal and rostral anterior cingulate 27 , and microstructural white matter abnormalities likely contributing to disconnection between these brain regions and to poor treatment response 28 . In late-life depression low functional connectivity between the anterior cingulate cortex and the dorsolateral prefrontal cortex has been found to be associated with poor remission rate during treatment with escitalopram 12 .
Prognosis of Cognitive Impairment in Late-Life Depression
Mild cognitive impairment during depressive episodes in late-life does not progress to dementia in most cases. Instead, it is often a stable disturbance that either persists or improves only when depressive symptoms are ameliorated 3, [29] [30] [31] . However, severe cognitive symptoms in geriatric depression patients do appear to result in an increased risk for developing dementia 20 . The variability in the cognitive abnormalities seen in geriatric depression suggests that this syndrome represents heterogeneous disorders 29 . Many depressed older adults do not have significant cognitive impairment 2 . In those with depression and cognitive impairment, the two syndromes may have a common cause (e.g., vascular disease 11 ) or simply co-exist and have distinct causes (e.g. a recurrence of earlyonset depression in an older patient with early stage Alzheimer's disease) 8 . Depressive symptoms may also be a prodrome (early symptom) of a dementing disorder. Finally, depressive disorder with onset in early life can be a risk factor for both Alzheimer's disease and vascular dementia [30] [31] [32] .
Neuropsychological assessment can aid the differential diagnosis of geriatric patients with depression and cognitive impairment (Table 1) . Notably, select cognitive deficits may help differentiate depressed patients who are likely to experience cognitive decline compared to depressed patients who remain cognitively stable. Rushing et al. 9 contrasted baseline performance on multiple cognitive measures and found that only recall of narrative contextual information (i.e., short stories) predicted conversion to dementia in the 15 out of 120 older adults with major depression who developed Alzheimer's disease up to 13 years later. Tests of executive functioning and executive-dependent word-list recall did not add significant value to the dementia prediction model. Thus, impaired memory for verbal contextual information, dependent on intact hippocampal functioning, may predict conversion to Alzheimer's disease in geriatric depression, whereas mild impairment in frontally mediated executive functions may not. This is consistent with evidence from nondepressed older adults, namely that the amnestic subtype of mild cognitive impairment, is associated with a progression to Alzheimer's disease whereas the dysexecutive subtype is associated with vascular disease 33 .
Evaluation of Cognitive Impairment in the Elderly
Evaluation of depressive syndromes in cognitively impaired patients is complicated by the symptom overlap with dementia, the instability of depressive symptoms over time, and the poor ability of elderly patients to report their symptoms. If criteria for one of the depressive syndromes are met, an antidepressant treatment trial should be offered 37 . Beyond the benefits of alleviating the suffering and complications of depression, remission of the depressive syndrome can increase the clinician's ability to evaluate the severity of the remaining cognitive impairment and plan for further treatment and follow up. Screening tests and questionnaires can be useful to detect select aspects of cognitive impairment. While the Mini Mental State Examination (MMSE), and Montreal Cognitive Assessment (Table 1 ) are relatively ubiquitous screening measures for gross cognitive impairment other instruments including the Mattis Dementia Rating scale (DRS-2) ( Table 1) 34 and Executive Interview (EXIT) 35 may be more sensitive to generalized cognitive decline 36 . The Cornell Scale for Depression in Dementia may also aid in quantifying depressive symptoms and signs; this scale integrates informant with patient reports 37 . Among patients with suspected executive dysfunction who perform well on traditional measures of executive functioning, the Frontal Systems Behavior Scale (FrSBe) 38 can help characterize behavioral manifestations of executive deficits. For instance, on the FrSBe, patients and informants rate the presence of behavioral syndromes of apathy and disinhibition as well as difficulties in working memory, planning, sequencing, organizing, and abstracting. In addition to characterizing executive dysfunction, preliminary evidence suggests that behavioral abnormalities identified by the FrSBe are associated with slower response of late-life depression to escitalopram 39 . The usefulness of screening measures and questionnaires is limited in situations where the cognitive deficits are subtle, there is concern about a comorbid dementia or the patient and/or family member is not a reliable informant in the case of questionnaires. In such cases, clinicians concerned about cognitive dysfunction should refer for a neurological and/or neuropsychological consultation (see Table 1 for examples of cognitive functions that should be assessed) 40 . Variability in the course of elders with depression and cognitive impairment suggests the need for careful follow up.
Pharmacologic Treatment
The Expert Consensus Guideline recommends antidepressant drug therapy combined with a psychosocial intervention as the treatment of choice for geriatric depression 41 . Tricyclic antidepressants have not been found to improve cognitive function in depressed older adults. In fact, nortriptyline was shown to compromise verbal learning performance of depressed older adults more than placebo 42 . Conversely, some Selective Serotonin Reuptake Inhibitors (SSRIs) may improve cognitive function mainly in patients whose depressive symptoms subside after treatment. Specifically, sertraline has been shown to improve performance on tests of attention, episodic memory, and executive function, but only in treatment responders 43 . Similarly, depressed older patients with an antidepressant response to citalopram showed improvement in psychomotor speed and visuospatial functioning. However, citalopram treatment appeared to worsen verbal learning and processing speed in patients who remained depressed despite treatment 44 . In contrast there is mounting preliminary evidence from both animal and human studies 45, 46 showing improvement of both mood and cognitive functioning with vortioxetene; however, studies in humans are limited, and additional research is needed in humans to substantiate effects on cognition.
Nevertheless, a substantial number of depressed older patients continue to experience residual depressive symptoms and neuropsychological deficits after antidepressant treatment. Abnormal executive functions, processing speed and working memory persist after remission of mood symptoms in many patients with geriatric depression [47] [48] [49] . In addition, some demographic variables may leave patients more vulnerable to persistent cognitive dysfunction despite treatment: Old age, high vascular risk score, and low baseline Mini Mental State Examination scores all predicted less cognitive improvement in depressed older adults treated with citalopram 43 .
Treatment of depression with sertraline 50 or mirtazapine 51 in Alzheimer's disease does not improve depressive symptoms more than placebo. Further, SSRI treatment is also associated with increased adverse events suggesting that their use for first-line treatment for depression should be reconsidered 51 .
Psychotherapies for Late-Life Depression with Cognitive
Impairment Non-pharmacological interventions should be considered in conjunction with pharmacotherapy or given alone in depression of mild to moderate severity 52 . Specific psychotherapies have also been developed to remedy the behavioral deficits of depressed older adults with cognitive impairments associated with poor response to antidepressants (see Table 2 [53] [54] [55] [56] [57] [58] [59] [60] ). As an example, problem-solving therapy (PST) was modified to address the behavioral deficits of patients with late-life depression and executive dysfunction 61 and has been efficacious in reducing depression and disability in cognitively unimpaired depressed older adults and in older adults with cognitive impairment 53, 54, 62 . PST is based on the premise that helping patients become better managers of their lives reduces stress and thus ameliorates depression. Patients are instructed to identify problems, brainstorm different ways to solve problems, create action plans, perform a cost-benefit analysis, and evaluate the effectiveness of potential solutions. PST improves skills needed in interpersonal relationships, remedies communication deficits, and increases behavioral activation by enhancing exposure to pleasurable activities. Further, recently therapies have been developed for depressed elderly patients that incorporate the modification of the patient's environment or "ecosystem" which includes the patient, the caregiver, and the patient's home environment (see 'EFT' Table 2) 57 . In addition to utilizing PST as a basic therapeutic framework, Problem Adaptation Therapy or PATH (Table 2) integrates environmental adaptation tools and the primary caregiver to help the patient circumvent their cognitive impairment and engage in problem resolution and adaptive functioning 53 .
Computerized Cognitive Remediation
Certain types of computerized cognitive remediation can improve brain functioning by inducing neuroplasticity (nCCR). 63, 64 We have proposed that computerized cognitive remediation that relies on the induction of neuroplasticity and targets brain networks associated with clinical outcomes in late life depression has the potential to improve treatment response. Recently, we developed a novel treatment model using nCCR to improve the functioning of cerebral networks responsible for executive functioning and associated with poor response to antidepressants 65 . Our nCCR treatment model is based on the assumption that neuroplastic changes that improve the function of cerebral network abnormalities contributing to antidepressant resistance (i.e. dorsal neocortical structures participating in the cognitive control network) would improve symptoms and signs of latelife depression. Preliminary evidence suggests that nCCR treatment induces a clinically meaningful improvement of both cognitive and affective symptoms in depressed elderly patients who failed to remit using conventional antidepressants. In fact 72% of patients reached remission after 4 weeks of treatment with nCCR. 66 
Future Investigations
Classic neuropsychological tests of executive functioning primarily assess the cognitive control network and offer little information on the ventromedial prefrontal regions. Ventromedial prefrontal regions, including the orbitofrontal cortex, ventral-rostral anterior cingulate, and their connections with the amygdala, mediate divergent functions such as processing of emotional information, utilization of cues in the environment to predict rewarding or aversive events, and the regulation of behavioral responses 67 . The ventromedial region also mediates reward-related decision-making, a complex task involving option generation, evaluation of risks and consequences, and choice of a course of action 68 . Ventromedial dysfunction is prominent in major depression 69 , yet ventromedial behavioral abnormalities have seldom been investigated in late-life depression. We recently treated an elderly woman with major depression who presented with mood lability, distractibility, poor self-monitoring, and impulsivity, yet demonstrated no impairment on classic tests of executive function 70 . Ventromedial behavioral disturbances, potentially dissociable from cognitive control dysfunction, may characterize a subgroup of late-life depression patients whose neurobiology, treatment response, and course of illness require further investigation.
The need to assess ventromedial functioning led to the development of Stroop-like emotional conflict tasks (e.g., categorizing facial affect while ignoring overlaid affect label words) 71 and decision-making paradigms, such as the Iowa Gambling Task. 72 When performing the Iowa, individuals select cards, one at a time, from one of four decks. Half of the decks are disadvantageous (i.e, higher immediate rewards but long-term negative outcomes) and the other half is advantageous (i.e., lower immediate rewards but long-term positive outcomes). Overall, older adults with major depression do not differ from agematched controls on the Iowa or other gambling paradigms. 73, 74 However, older adults with major depression and clinical evidence of poor decision-making (as evidenced by a history of attempted suicide) perform worse on a gambling task when compared to older depressed adults with no history of suicide. 73 In contrast, apathetic, depressed elderly patients are not influenced by immediate reinforcers (the high rewards of the disadvantageous decks)and demonstrate an advantageous strategy on the Iowa Gambling Task (selecting cards from the conservative decks) when compared to non-apathetic, depressed older adults. 74 Elucidating the neurocognitive outcome of geriatric depression patients with ventromedial disturbance remains ongoing.
Conclusions
Major depression in the elderly is often accompanied by impairment 75 spanning across multiple cognitive domains 14 . Most depressed older adults do not develop neurodegenerative diseases, yet some cases of late-onset depression represent the first behavioral abnormalities of dementia syndromes. In some cases, depression and cognitive impairment may be related to a single underlying illness, e.g. cerebrovascular disease, in others, neurodevelopmental disease and depression simply coexist. Deficits in executive functions (i.e. susceptibility to interference, and semantic strategy) have important clinical implications such as: Poor, slow and unstable response of depression to antidepressant drugs, early relapse and recurrence, increased risk of suicidality, and disability disproportional to the severity of depression. In the majority of patients, pharmacological treatment does not lead to major improvement in cognition. Though there are a few exceptions. Therefore, it is important to clarify the patients' cognitive status early so that appropriate treatment recommendations can be made.
Psychotherapies have been developed to address the behavioral deficits of depression with executive dysfunction (PST), as well as in patients with depression and dementia (PATH) and patients with post-stroke depression (EFT). These approaches have been found to be effective to improve depression and disability. Neuroplasticity based computerized cognitive remediation targeting brain networks responsible for executive functioning has been developed, and preliminary studies are encouraging. More studies are needed in this emerging area. Behavior Therapy -Positive Events (BT-PE) 59 Depressed older adults with moderate to severe dementia and their caregivers Outpatient setting 9 weekly sessions Behavioral strategies (e.g., identifying, planning, and carrying out positive activities as well as identifying and eliminating obstacles).
Behavior Therapy -Problem-solving (BT-PS) 59 Depressed older adults with moderate to severe dementia and their caregivers Outpatient setting 9 weekly sessions Problem-solving skills training to caregivers; education, advice, and support to caregivers.
Interpersonal Psychotherapy for Mild Cognitive Impairment (IPT-CI) 60 Depressed older adults with mild cognitive impairment Outpatient setting 12-16 weekly sessions Interpersonal skills, joint caregiver-patient sessions.
Personalized Adherence Intervention for Depression and COPD (PID-C) 55 Depressed older adults with COPD Outpatient setting 9 weekly sessions Skills to target barriers to adherence (i.e. misconceptions, misunderstanding of recommendations, misattribution of symptoms, stigma, hopelessness, dissatisfaction with treatment experience, logistic barriers).
Ecosystem Focused Therapy (EFT) 57 Older adults with post-stroke depression Patient's home 12 weekly sessions New perspective, adherence enhancement structure, problem solving structure, re-engineering goals and plans of family, coordination of specialized therapists.
Engage 56
Depressed older adults Outpatient setting 9 weekly sessions Reward exposure (action planning to increase rewarding activities). Behavioral techniques targeting barriers (negativity bias, apathy, emotional dysregulation) to reward exposure.
